World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02203097
Date of registration: 25/07/2014
Prospective Registration: No
Primary sponsor: University of Debrecen
Public title: The Effect of Different End-tidal Carbon-dioxide Levels on Cerebral CO2 Vasoreactivity and the Stiffness of Systemic Arteries During Propofol Anesthesia
Scientific title: The Effect of Different End-tidal Carbon-dioxide Levels on Cerebral CO2 Vasoreactivity and the Stiffness of Systemic Arteries During Propofol Anesthesia
Date of first enrolment: January 2014
Target sample size: 25
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02203097
Study type:  Interventional
Study design:  Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).  
Phase:  Phase 4
Countries of recruitment
Hungary
Contacts
Name:     Csilla Molnár, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care 4032-Debrecen, Nagyerdei krt 98. Hungary Tel/fax: +36-52-255-347
Key inclusion & exclusion criteria

Inclusion Criteria:

- Above the age 18

- American Society of Anesthesiologists (ASA) physical classification I. or II.

- Patients undergoing elective varicotomy, inguinal hernioplasty or breast surgery in
general anesthesia

Exclusion Criteria:

- Patients with cerebral, cardiac or systemic vascular disorders (hypertension,
diabetes)

- Patients receiving medication that affects the blood vessels (antihypertensive,
antidiabetic, antiarrhythmic medications)



Age minimum: 18 Years
Age maximum: 50 Years
Gender: All
Health Condition(s) or Problem(s) studied
Propofol-anaesthesia Via Target-controlled Infusion
Intervention(s)
Drug: Propofol
Procedure: Partial pressure of CO2 at the end of an exhaled breath
Primary Outcome(s)
Blood flow velocity in the middle cerebral artery [Time Frame: Changes from baseline in blood flow velocity at the 15th, 20th and 25th minutes of the operation]
Secondary Outcome(s)
Changes in the central systolic and diastolic blood pressure [Time Frame: Changes from baseline in central blood pressure at the 15th, 20th and 25th minutes of the operation]
Arterial wall stiffness of the radial artery [Time Frame: Changes from baseline in arterial stiffness at the 15th, 20th and 25th minutes of the operation]
Secondary ID(s)
030167-006/2014/OTIG
2345
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history